Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004352 (
autism
)
32,579
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Autism
spectrum disorders (ASDs) are a group of neurodevelopmental disorders with high heritability, although their underlying genetic factors are still largely unknown. Here we present a comprehensive genetic characterization of two ASD siblings from Sardinia by genome-wide copy number variation analysis and whole exome sequencing (WES), to identify novel genetic alterations associated with this disorder. Single nucleotide polymorphism (SNP) array data revealed a rare microdeletion involving
CAPG
,
ELMOD3,
and
SH2D6
genes, in both siblings.
CAPG
encodes for a postsynaptic density (PSD) protein known to regulate spine morphogenesis and synaptic formation. The reduced
CAPG
mRNA and protein expression levels in ASD patients, in the presence of hemizygosity or a particular genetic and/or epigenetic background, highlighted the functional relevance of
CAPG
as a candidate gene for ASD. WES analysis led to the identification in both affected siblings of a rare frameshift mutation in
VDAC3
, a gene intolerant to loss of function mutation, encoding for a voltage-dependent anion channel localized on PSD. Moreover, four missense damaging variants were identified in genes intolerant to loss of function variation encoding for PSD proteins:
PLXNA2
,
KCTD16
,
ARHGAP21,
and
SLC4A1
. This study identifies
CAPG
and
VDAC3
as candidate genes and provides additional support for genes encoding PSD proteins in ASD susceptibility.
...
PMID:Analysis of a Sardinian Multiplex Family with Autism Spectrum Disorder Points to Post-Synaptic Density Gene Variants and Identifies
CAPG
as a Functionally Relevant Candidate Gene. 3073 58